Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 70 years old (inclusive), of any gender
- People who have at least one tumour that can be assessed, with a confirmed diagnosis of a malignant brain or central nervous system tumour, and imaging showing the tumour has continued to grow or come back after treatment
- People whose general physical functioning scores at least 60% on a standard medical performance scale, meaning they are able to care for themselves and are up and about more than half the time (confirm with trial site)
- People with a life expectancy of more than 4 weeks who are able to have an MRI scan with contrast dye
- People who finished radiotherapy or other systemic treatments (such as temozolomide, bevacizumab, or other medicines) at least 4 weeks before joining, and whose side effects from those treatments have mostly resolved to a mild or minimal level
- People taking no more than 4 mg per day of dexamethasone (a type of steroid), or an equivalent low dose of a similar medicine, or none at all
- People whose blood test results show that the bone marrow, liver, kidneys, and other organs are functioning adequately (the trial site will check specific blood values)
- People with no known hereditary diseases
- People with normal heart function, where the heart is pumping at more than 55% of its capacity
- People with no bleeding or blood clotting disorders
- People who have no sign of active bacterial, fungal, or viral infection in the blood, and no signs of meningitis (brain/spinal cord membrane infection), within 48 hours before receiving the treatment cells
- Women who could become pregnant must have had a negative pregnancy test within 7 days before starting treatment, and must be willing to use contraception during the trial and for 6 months after the last treatment session
- People who have read, understood, and signed the informed consent form
Who may not be able to join:
- People with active hepatitis B, hepatitis C, HIV infection, or any other untreated active infection
- People who are pregnant or breastfeeding
- People with organ failure
- People with a long-term (chronic) condition that requires ongoing immune-suppressing or hormonal treatment
- People with a known allergy to immunotherapy or the types of cells used in this treatment
- People with another serious illness that is not under control
- People with a psychiatric illness or personal circumstances that would make it difficult to follow the trial requirements
- People who have previously had an organ transplant or who are currently waiting for one
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: (+86)-135-1108-7060
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of Adverse Events (AEs); Incidence of Dose-Limiting Toxicities (DLTs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.